Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 4 Multiple Myeloma 3 Gastrointestinal Stromal Tumors 3 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Gastrointestinal Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

lutetium Lu 177 dotatate 2 Magnetic Resonance Spectroscopy 2 olaparib 1 gallium Ga 68 dotatate 1 capivasertib 1 abemaciclib 1 Surveys and Questionnaires 1 Sunitinib 1 Specimen Handling 1 Lysine 1 Hydroxyurea 1 HhAntag691 1 Ga(III)-DOTATOC 1 GSK2256098 1 Everolimus 1 Bevacizumab 1 Arginine 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × Sunitinib × 30 days × Clear all

NCT06955169 2026-05-22

MOMENTUM-1

RTOG Foundation, Inc.

Phase 2 Suspended

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡